The IntellisTM platform for the management of certain types of chronic intractable pain includes the world’s smallest implantable spinal cord stimulator (SCS) and offers personalized pain relief and advanced activity tracking. Neurostimulation has been proven to provide effective long-term pain relief and improve quality of life, in addition to being a treatment option for patients interested in trying a non-drug alternative.1-5

About Intellis

The Intellis platform was designed to overcome limitations with current SCS systems, such as battery performance, and can power the EvolveSM workflow, which standardizes guidance and balances high-dose (HD) and low-dose (LD) therapy settings.


  • Advanced Activity Tracking: The Intellis neurostimulator uses Snapshot™ reporting to record and track patient activity 24/7, enabling physicians to address the subjective and personal nature of chronic pain by monitoring progress and making modifications to better suit their patients’ therapy needs. This can help optimize treatment and improve patient-physician communication by tracking and sharing daily activities, body positions and therapy usage and by giving physicians an objective look at mobility and progress.

  • Reduced Recharge Burden: The Intellis platform addresses a common patient complaint: the daily or weekly recharge burden. With Medtronic’s proprietary Overdrive™ battery technology, the Intellis battery can be fully recharged from empty to full in approximately one hour and physicians can now estimate recharge intervals based on therapy settings.

  • Simplified Programming and Upgrades: The Intellis platform uses secure wireless clinician programmers managed on the Samsung Galaxy Tab S2 tablet interface that enable faster delivery of evolving workflows and software upgrades. The Evolve workflow is standardized guidance to simplify the trial and implant experience and optimize patient options.

  • Broadest MRI Access: The Intellis platform includes Medtronic’s proprietary SureScanTM MRI technology for the broadest access available to MRI diagnostic imaging and simplest eligibility determination, which allows MRI scans anywhere on the body under certain conditions.

  • Personalized Pain Relief: The Intellis platform includes AdaptiveStimTM technology for automatic adjustments to deliver the right therapy dose to the right location, as the pain target shifts based on body position.


Medtronic neurostimulation therapy for chronic intractable pain uses a medical device placed under a patient’s skin to deliver mild electrical impulses through a lead implanted in the epidural space to block pain signals from going to the brain. Multiple randomized controlled trials have demonstrated that SCS provides more effective pain relief than both re-operation and conventional medical management.1-3,7

Medtronic has the broadest portfolio of pain therapies, which have been in use for over 40 years and have benefited hundreds of thousands of patients worldwide. Medtronic developed and leads the field of neuromodulation, the targeted and regulated delivery of electrical pulses and pharmaceuticals to specific sites in the nervous system, and continues to innovate and bring patient-centric advances. 

For additional information on Intellis, please visit


  1. North RB., Kidd DH., Farrokhi F, et al. Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: a randomized, controlled trial. Neurosurg; 56: 98–106 (2005).

  2. Kumar K., Taylor RS., Jacques L, et al., Spinal cord stimulation versus conventional medical management for neuropathic pain: a multicenter randomised controlled trial in patients with failed back surgery syndrome. Pain; 132: 179–188. (2007).

  3. Kemler MA., De Vet HCW., Barendse GAM et al., The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years’ follow-up of the randomized controlled trial. Ann Neurol; 55: 13–18 (2004).

  4. Taylor RS, Spinal cord stimulation in Complex Regional Pain Syndrome and Refractory Neuropathic Back and Leg Pain/Failed Back Surgery Syndrome: results of a systematic review and meta-analysis. J Pain Symptom Manage; 31: S13–S19 (2006).

  5. Cameron T, Safety and efficacy of spinal cord stimulation for the treatment of chronic pain – a 20 year literature review. J Neurosurg Spine; 100: 254–267 (2004).

  6. Mekhail N, Wentzel DL, Freeman R, Quadri H. Counting the costs: case management implications of spinal cord stimulation treatment for failed back surgery syndrome. Prof Case Manag. 2011;16(1):27-36.

  7. Kumar K, Taylor RS, Jacques L, Eldabe S, Meglio M, Molet J, et al. The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery. 2008;63(4):762-70.